• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Cue Health

How Cue Health’s Covid-19 Test Became the Go-To for Business

March 1, 2022

Element Biosciences Partners With Informatics Experts Sentieon and Google DeepVariant to Validate the AVITI™ System’s NGS Data Quality for Variant Calling

February 28, 2022
Element Biosciences

Element Biosciences acquires Loop Genomics to add long-read tech to DNA sequencing platform

February 9, 2022
Alumis, Inc.

Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis

February 4, 2022
Detect, Inc.

As Omicron Spreads, New PCR-Like At-Home Covid Tests Provide Fast, Accurate Results

January 28, 2022
ImmPACT Bio, Inc.

Novartis-backed ImmPACT Bio snags $111M and new CEO as cancer CAR-T yields phase 1 results

January 20, 2022
Eikon Therapeutics

‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M

January 6, 2022
Bit Bio Limited

This Startup Is Making—and Programming—Human Cells

December 20, 2021
Everly Health

EXCLUSIVE: The parent company of home-health testing brand Everlywell is buying Natalist, a reproductive health startup

October 21, 2021
Evonetix

Evonetix granted patent for DNA data storage and retrieval method

September 30, 2021
Page 5 of 26« First«...34567...1020...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2026 Foresite Capital Management, LLC.

    Site by Goodlab

    Close